Press release
Clear Vision for Growth: Eylea Market Unveils Market Size, Scope, and Lucrative Opportunities
Eylea Global Market Report 2024
The Business Research Company offers in-depth market insights through Eylea Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The eylea market size has grown strongly in recent years. It will grow from $7.8 billion in 2023 to $8.19 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to diabetic macular edema (dme) prevalence, clinical efficacy and safety profile, competition with other anti-vegf therapies, approval for various retinal conditions, shift towards intravitreal injections..
The eylea market size is expected to see strong growth in the next few years. It will grow to $10.16 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to emerging therapeutic indications, introduction of biosimilar competition, increasing awareness and diagnosis, real-world evidence and post-market studies, patient preference for less frequent injections.. Major trends in the forecast period include advancements in imaging technologies, telemedicine and remote monitoring, patient assistance programs, advances in drug delivery technologies, retinal imaging technologies, clinical trials for new indications..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=9155&type=smp
Market Segmentation:
The eylea market covered in this report is segmented -
1) By Product: Prefilled Syringe Package, Vial Package
2) By Disorder: Wet Age-Related Macular Degeneration (AMD), Diabetic Retinopathy, Other Disorders
3) By Application: Hospitals, Retail Pharmacy, Other Applications
Major Driver - Eylea Market Thrives On Addressing The Rise In Ocular Diseases
The increasing prevalence of ocular diseases is expected to propel the Eylea market. Ocular diseases refer to an eye condition that interferes with the ability of the eye properly function and negatively affects the vision and clarity of the eye. They often don't have any symptoms until they have become very advanced. Eylea treats conditions such as ocular diseases including wet age-related macular degeneration (AMD) and glaucoma, which damages the retina or macula that affects the vision. Eylea blocks the protein that develops new weaker blood vessels and slows down the retina's swelling caused by a blockage in the blood vessels. For instance, in October 2022, according to the BrightFocus Foundation, a US-based nonprofit organization dedicated to advancing research and support for macular degeneration and glaucoma, there were currently 80 million individuals with glaucoma across the globe, with a projected increase to more than 111 million by the year 2040. Therefore, the increasing prevalence of ocular diseases is driving the Eylea market.
Competitive Landscape:
Major companies operating in the eylea market report are Regeneron Pharmaceuticals Inc., Bayer AG, Santen Pharmaceutical Co Ltd, Momenta Pharmaceuticals Inc., Novartis AG, Mylan NV, Vertex Pharmaceuticals Incorporated, Alvotech Switzerland AG, Sanofi SA, F Hoffmann-La Roche AG, PV Pharma, Alteogen Inc., Viatris Inc., Biocon Biologics Limited, Nexus Lifecare Pvt Ltd, AbbVie Inc., Alcon Inc., Alkem Laboratories Ltd., Intas Pharmaceuticals Ltd., Amgen Inc., Apotex Inc., Aurobindo Pharma Ltd., Lupin Ltd., Biogen Inc., Bristol-Myers Squibb Company, Cipla Ltd, Dr. Reddy's Laboratories Ltd, Merck & Co. Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC .
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/eylea-global-market-report
Top Trend - Research And Development Elevate The Eylea Market
Research and developments are a key trend gaining popularity in the eylea market. Developing cutting-edge technical solutions is a top priority for the major industry players in eylea. For instance, in August 2023, Regeneron Pharmaceuticals, Inc., a US-based global biotechnology company developing medicine for serious diseases, received US FDA approval for Eylea HD (aflibercept) injection 8 mg to address patients with wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and diabetic retinopathy (DR). The administration schedule involves an initial period of every four weeks for the first three months across all indications, followed by adjusted intervals of every eight to 16 weeks for wAMD and DME, and every eight to 12 weeks for diabetic retinopathy.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Eylea Market Characteristics
3. Eylea Market Trends And Strategies
4. Eylea Market - Macro Economic Scenario
5. Eylea Market Size And Growth
…..
27. Eylea Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Clear Vision for Growth: Eylea Market Unveils Market Size, Scope, and Lucrative Opportunities here
News-ID: 3405235 • Views: …
More Releases from The Business research company
Evolving Market Trends In The Integrated Geophysical Services Industry: Enhancin …
The Integrated Geophysical Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Integrated Geophysical Services Market Size During the Forecast Period?
The integrated geophysical services market has experienced consistent growth in recent years, expected to rise from $2.35 billion in 2024 to…
Global HR Advisory Services Market: Key Trends, Market Share, Growth Drivers, An …
The HR advisory services market report describes and explains the HR advisory services market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global HR advisory services market reached a value of nearly $155.74 billion in 2024, having grown at a compound annual growth rate (CAGR) of 4.22% since…
High Voltage Aluminium Electrolytic Capacitors Global Market Report 2025: Size, …
The high voltage aluminum electrolytic capacitors report describes and explains the high voltage aluminum electrolytic capacitors market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global high voltage aluminum electrolytic capacitors market reached a value of nearly $4.10301 billion in 2024, having grown at a compound annual growth…
Global Vertical Market Software Market: Key Trends, Market Share, Growth Drivers …
The vertical market software report describes and explains the vertical market software market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global vertical market software market reached a value of nearly $152.61027 billion in 2024, having grown at a compound annual growth rate (CAGR) of 12.11% since 2019.…
More Releases for Eylea
Eylea Market Emerging Trends and Growth Prospects 2034
Eylea market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Eylea Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The…
Eylea Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share
What market dynamics are playing a key role in accelerating the growth of the eylea market?
The Eylea market is anticipated to expand with the escalating incidence of eye ailments. These ocular maladies interfere with the precise functioning of the eye and can negatively influence visual clarity. Often, these issues remain symptomless until reaching a critical stage. Eylea is beneficial in addressing conditions like wet age-related macular degeneration (AMD) and glaucoma,…
Eylea Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share
What market dynamics are playing a key role in accelerating the growth of the eylea market?
The Eylea market is anticipated to expand with the escalating incidence of eye ailments. These ocular maladies interfere with the precise functioning of the eye and can negatively influence visual clarity. Often, these issues remain symptomless until reaching a critical stage. Eylea is beneficial in addressing conditions like wet age-related macular degeneration (AMD) and glaucoma,…
Global EYLEA Drug Market Imapct of AI and Automation
EYLEA Drug Market Impact of AI and Automation
In 2022, the EYLEA drug market was valued at approximately $7.3 billion. The market is projected to experience a compound annual growth rate (CAGR) of 7.5% from 2022 to 2030. This growth trajectory highlights a robust expansion in the treatment of retinal diseases, reflecting both increasing patient populations and advancements in medical technology. The ultimate drivers of this growth include ongoing research and…
Eylea Market Growth, Trends & Competitive Analysis 2024-2033
The Business Research Company recently released a comprehensive report on the Global Eylea Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The eylea market size has…
Eylea Market 2024 Report By Key Companies, Regional Analysis And Forecast 2033
The new report published by The Business Research Company, titled "Eylea Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the eylea market size has grown strongly in recent years. It will grow from $7.8 billion in 2023 to…
